Lemborexant for insomnia in people with mental health conditions
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This study tests if lemborexant, a sleep medication, can help people with both a mental health condition and insomnia. You would take the medicine as prescribed and complete questionnaires over 2 months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have been diagnosed with a mental health condition (like depression, anxiety, or bipolar disorder)
- You have trouble sleeping, with a score of at least 11 on the Insomnia Severity Index
- You have at least 7 hours available for sleep each night
- You are able to attend follow-up visits for 2 months
- Your doctor recommends trying a sleep medication called lemborexant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a medication called Lemborexant can improve sleep problems and movement symptoms in people with Parkinson's disease. If you have trouble sleeping due to insomnia and have had Parkinson's for at least 2 years, this study may help.
This study tests if the sleep medication lemborexant can help people with opioid use disorder who also have chronic insomnia. Participants must already be taking buprenorphine (Suboxone) for at least 4 weeks. The goal is to see if better sleep improves mood and reduces opioid use.
This trial tests whether a medication that blocks brain chemicals involved in wakefulness can help reduce markers of nerve damage in people with insomnia. It is for adults aged 40–65 with chronic insomnia, and it aims to see if improving sleep may protect brain health.
This trial tests if the sleep medication lemborexant can help people with early-stage dementia who also have insomnia. It uses an N-of-1 design, meaning it will look at how you personally respond to the drug compared to a placebo.
This trial tests whether a part of the brain called the locus coeruleus is involved in insomnia. It involves sleep questionnaires and possibly brain imaging to understand your sleep problems better.
This study tests whether a new sleep medication called daridorexant helps people with depression who also struggle with insomnia. You would take this medication for several weeks while researchers track how it affects your sleep and mood.
Hear when a new Insomnia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.